Results 81 to 90 of about 22,605 (200)

Comparative study of efficacy of different iron chelating agents in treatment of iron overload in children with Beta Thalassemia Major

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2014
Backgrounds: Beta thalassemia is hereditary blood disorder characterized by reduced or absent beta chains of hemoglobin resulting in imbalanced globin chain synthesis with early destruction of RBCs and anemia.
adel abd elhaleim hagag
doaj  

Identification of Staphylococcus epidermidis and Staphylococcus hominis from blood cultures by testing susceptibility to desferrioxamine

open access: yes, 1993
Testing susceptibility to desferrioxamine has recently been described as a method for the identification of Staphylococcus epidermidis. This method was compared to a commercial test and the tube coagulase test for the identification of staphylococci from
Riley, T.V.   +5 more
core   +1 more source

Desferrioxamine treatment of iron overload secondary to RH isoimmunization and intrauterine transfusion in a newborn infant

open access: yes, 2011
Intrauterine transfusion is the standard of care in the management of severe Rh isoimmunization. Desferrioxamine has been used for the treatment of iron overload secondary to hemolysis and intrauterine transfusions in Rh isoimmunization cases.
Arikan, Cigdem   +15 more
core   +1 more source

Identification of a Cluster of Genes that Directs Desferrioxamine Biosynthesis in Streptomyces coelicolor M145

open access: yes, 2016
Desferrioxamines are a structurally related family of tris-hydroxamate siderophores that form strong hexadentate complexes with ferric iron. Desferrioxamine B has been used clinically for the treatment of iron overload in man.
Francisco Barona-Gómez (2699224)   +4 more
core   +1 more source

Chelator-facilitated removal of iron from transferrin: Relevance to combined chelation therapy [PDF]

open access: yes, 2008
Current iron chelation therapy consists primarily of DFO (desferrioxamine), which has to be administered via intravenous infusion, together with deferiprone and deferasirox, which are orally-active chelators.
Evans, PJ   +3 more
core  

Synthesis of biocompatible poly(ε-caprolactone)-block-poly(propylene adipate) copolymers appropriate for drug nanoencapsulation in the form of core-shell nanoparticles

open access: yesInternational Journal of Nanomedicine, 2011
Stavroula G Nanaki1, Kostas Pantopoulos2, Dimitrios N Bikiaris11Laboratory of Polymer Chemistry and Technology, Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece; 2Lady Davis Institute for Medical Research and
Nanaki SG, Pantopoulos K, Bikiaris DN
doaj  

An Evaluation of Sensory Neural Hearing Loss in Thalassaemic Patients Treated with Desferrioxamine and Its Risk Factors

open access: yesJournal of Research in Medical Sciences, 2005
Back ground: In major thalassaemia patients who need blood transfusion, iron overload is a major therapeutic disadvantage that leads to heart failure which is the major cause of death in such patients.
M Sonbolestan, F Mokhtarinejad, M Omrani
doaj  

The prophylactic effects of superoxide dismutase, catalase, desferrioxamine, verapamil and disulfiram in experimental colitis

open access: yes, 1997
In our study we have tried to compare the prophylactic effects of superoxide dismutase (SOD), SOD+catalase (CAT), desferrioxamine, verapamil and disulfiram, which are all free oxygen radical (FOR) scavengers, in an animal model of experimental acetic ...
Koksoy, FN   +4 more
core  

Desferrioxamine attenuates pancreatic injury after major hepatectomy under vascular control of the liver: Experimental study in pigs

open access: yes, 2012
Introduction. Pancreatic injury can manifest after major hepatectomy under vascular control. The main mechanism involved seems to be remote oxidative injury due to spillage of reactive oxygen species and cytokines from the liver. The aim of this study is
Arkadopoulos, N.   +11 more
core   +1 more source

Single centre retrospective study of patients receiving desferrioxamine through PICC line

open access: yesPediatric Hematology Oncology Journal, 2022
Shruti Kakkar   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy